RE:RE:RE:RE:RE:RE:Annual meeting SPCEO1, have to disagree with you there. That was not a news release to try and increase the share price. The record quarterly sales, NASH phase 3 and start of Oncology had to be made public before the offering could happen. I think the news release was done in a way to try and keep the share price from running too high above the agreed upon offering price. You can't tell me this was meant to try and increase the share price while announcing the 3 best developments this company has had in years. If that was an attempt to increase the share price someone should have been fired on the spot:
"Theratechnologies outlines F2020 net revenue estimate
2021-01-07 07:34 ET - News Release"
SPCEO1 wrote: My best guess is that the company would not have even said anything about the letter to proceed on the NASH trial if they were not doing the OO. They wanted to put whatever they could out there to get the share price higher before the OO